EPIZYME, INC. Revenue
EPIZYME, INC. reported Revenue of $27.53 million for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-09.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2022-08-09
- EPIZYME, INC. revenues for the quarter ending 2022-06-30 was $27.53M, a 111.59% increase year-over-year.
- EPIZYME, INC. revenues for the quarter ending 2022-03-31 was $8.70M, a 13.96% increase year-over-year.
- EPIZYME, INC. revenues for the quarter ending 2021-12-31 was $11.58M, a 38.30% increase year-over-year.
- EPIZYME, INC. revenues for the quarter ending 2021-09-30 was $5.20M, a 45.85% increase year-over-year.
- EPIZYME, INC. revenues for fiscal 2021 was $37.43M, a 137.45% increase from fiscal 2020.
- EPIZYME, INC. revenues for fiscal 2020 was $15.76M, a 33.77% decline from fiscal 2019.
- EPIZYME, INC. revenues for fiscal 2019 was $23.80M, a 9.68% increase from fiscal 2018.
- EPIZYME, INC. revenues for fiscal 2018 was $21.70M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2022-06-30 | $27.53M 10-Q · filed 2022-08-09 | $36.22M 10-Q · filed 2022-08-09 | $47.81M derived: sum of 3 quarters · filed 2022-08-09 | $53.01M derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | $8.70M 10-Q · filed 2022-05-10 | $20.28M derived: sum of 2 quarters · filed 2022-05-10 | $25.48M derived: sum of 3 quarters · filed 2022-05-10 | $38.49M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-12-31 | $11.58M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $16.78M derived: sum of 2 quarters · filed 2022-03-01 | $29.79M derived: sum of 3 quarters · filed 2022-08-09 | $37.43M 10-K · filed 2022-03-01 |
| 2021-09-30 | $5.20M 10-Q · filed 2021-11-09 | $18.21M derived: sum of 2 quarters · filed 2022-08-09 | $25.84M 10-Q · filed 2021-11-09 | $34.22M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-06-30 | $13.01M 10-Q · filed 2022-08-09 | $20.64M 10-Q · filed 2022-08-09 | $29.02M derived: sum of 3 quarters · filed 2022-08-09 | $32.58M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $7.63M 10-Q · filed 2022-05-10 | $16.01M derived: sum of 2 quarters · filed 2022-05-10 | $19.57M derived: sum of 3 quarters · filed 2022-05-10 | $22.04M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $8.38M 10-K · filed 2021-02-23 | $11.94M derived: sum of 2 quarters · filed 2021-11-09 | $14.41M derived: sum of 3 quarters · filed 2021-11-09 | $15.76M 10-K · filed 2022-03-01 |
| 2020-09-30 | $3.57M 10-Q · filed 2021-11-09 | $6.03M derived: sum of 2 quarters · filed 2021-11-09 | $7.39M 10-Q · filed 2021-11-09 | $11.68M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $2.47M 10-Q · filed 2021-08-09 | $3.82M 10-Q · filed 2021-08-09 | $8.12M derived: sum of 3 quarters · filed 2021-08-09 | $13.83M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $1.35M 10-Q · filed 2021-05-06 | $5.65M derived: sum of 2 quarters · filed 2021-05-06 | $11.36M derived: sum of 3 quarters · filed 2021-05-06 | $17.26M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $4.29M 10-K · filed 2021-02-23 | $10.01M derived: sum of 2 quarters · filed 2021-02-23 | $15.91M derived: sum of 3 quarters · filed 2021-02-23 | $23.80M 10-K · filed 2022-03-01 |
| 2019-09-30 | $5.71M 10-K · filed 2021-02-23 | $11.62M derived: sum of 2 quarters · filed 2021-02-23 | $19.51M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $5.90M 10-K · filed 2021-02-23 | $13.79M 10-Q · filed 2020-08-04 | ||
| 2019-03-31 | $7.89M 10-K · filed 2021-02-23 | |||
| 2018-12-31 | $21.70M 10-K · filed 2021-02-23 |